Follow The Filings

BNTX BioNTech

BioNTech earnings company data as of 7:06 PM ET 10/30

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 3 Nov EPS 0.82 — —
Rev $1.04B — —

Insider trades

Open-market buys and sales by BNTX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BNTX insider trades
  • None no insider bought on the open market
  • None no sales outside a trading plan
  • $89.8M sold by 2 insiders under 10b5-1 plans
  1. Ugur Sahin CEO
    Planned sale
    $5.9M 63,209 shares at $94.07 100% of stake
    Traded Oct 8–9 Filed Oct 9
  2. Ugur Sahin CEO
    Planned sale
    $2.3M 24,000 shares at $95.86 28% of stake
    Traded Oct 7 Filed Oct 7
  3. Ugur Sahin CEO
    Planned sale
    $9M 93,000 shares at $97.14 52% of stake
    Traded Oct 5–6 Filed Oct 6
  4. Ugur Sahin CEO
    Planned sale
    $3.3M 34,000 shares at $97.09 16% of stake
    Traded Oct 1–2 Filed Oct 2
  5. Ugur Sahin CEO
    Planned sale
    $6.5M 66,000 shares at $98.19 24% of stake
    Traded Sep 29–30 Filed Sep 30
  6. Ugur Sahin CEO
    Planned sale
    $6M 61,000 shares at $98.57 18% of stake
    Traded Sep 25–28 Filed Sep 28
  7. Ugur Sahin CEO
    Planned sale
    $6.8M 69,000 shares at $99.17 17% of stake
    Traded Sep 23–24 Filed Sep 24
  8. Ugur Sahin CEO
    Planned sale
    $7.9M 79,000 shares at $99.50 16% of stake
    Traded Sep 21–22 Filed Sep 22
  9. Ugur Sahin CEO
    Planned sale
    $6.2M 64,000 shares at $97.49 12% of stake
    Traded Sep 17–18 Filed Sep 18
  10. Ugur Sahin CEO
    Planned sale
    $4.7M 49,000 shares at $96.37 8.1% of stake
    Traded Sep 15–16 Filed Sep 16
  11. Ugur Sahin CEO
    Planned sale
    $8.4M 86,000 shares at $98.13 13% of stake
    Traded Sep 11–14 Filed Sep 14
  12. Ugur Sahin CEO
    Planned sale
    $2M 20,500 shares at $96.31 2.9% of stake
    Traded Sep 10 Filed Sep 11
  13. Ugur Sahin CEO
    Planned sale
    $7.2M 73,000 shares at $98.50 9.3% of stake
    Traded Sep 8–9 Filed Sep 9
  14. Ugur Sahin CEO
    Planned sale
    $7.9M 76,500 shares at $103.12 8.9% of stake
    Traded Sep 3–4 Filed Sep 8
  15. Sierk Poetting COO
    Planned sale
    $5.5M 50,000 shares at $110.56 11% of stake
    Traded Apr 22 Filed Apr 23

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
6-K
20-F/A
6-K
6-K
6-K
6-K
SCHEDULE 13G/A —
6-K
SCHEDULE 13G/A —

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.